 Jesse Davidson
Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiopulmonary Bypass | 10 | 2022 | 246 | 5.600 |
Why?
| | Alkaline Phosphatase | 6 | 2019 | 157 | 3.310 |
Why?
| | Cardiac Surgical Procedures | 6 | 2022 | 474 | 3.090 |
Why?
| | Acute Kidney Injury | 3 | 2022 | 612 | 1.630 |
Why?
| | Postoperative Complications | 8 | 2021 | 2181 | 1.590 |
Why?
| | Endothelin-1 | 2 | 2022 | 170 | 1.480 |
Why?
| | Heart Arrest | 3 | 2020 | 327 | 1.300 |
Why?
| | Heart Defects, Congenital | 3 | 2022 | 707 | 1.300 |
Why?
| | Adenosine | 2 | 2018 | 217 | 1.150 |
Why?
| | Kynurenine | 2 | 2021 | 69 | 1.010 |
Why?
| | Tryptophan | 2 | 2022 | 135 | 1.000 |
Why?
| | Infant | 16 | 2022 | 8097 | 0.970 |
Why?
| | Heart Bypass, Right | 1 | 2022 | 18 | 0.920 |
Why?
| | Prospective Studies | 11 | 2022 | 6288 | 0.830 |
Why?
| | Metabolomics | 3 | 2021 | 519 | 0.820 |
Why?
| | Arrhythmias, Cardiac | 2 | 2020 | 327 | 0.810 |
Why?
| | Coronary Care Units | 1 | 2018 | 19 | 0.750 |
Why?
| | Interleukin-1 Receptor-Like 1 Protein | 1 | 2019 | 25 | 0.740 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2019 | 112 | 0.710 |
Why?
| | Fontan Procedure | 1 | 2020 | 154 | 0.710 |
Why?
| | Aortic Coarctation | 1 | 2019 | 64 | 0.710 |
Why?
| | Blood Proteins | 1 | 2020 | 258 | 0.700 |
Why?
| | Length of Stay | 4 | 2018 | 1071 | 0.700 |
Why?
| | Endotoxemia | 1 | 2019 | 100 | 0.700 |
Why?
| | 5'-Nucleotidase | 1 | 2018 | 34 | 0.690 |
Why?
| | Endotoxins | 1 | 2019 | 265 | 0.680 |
Why?
| | Biomarkers | 6 | 2020 | 3485 | 0.640 |
Why?
| | Ventricular Remodeling | 1 | 2019 | 204 | 0.640 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2018 | 158 | 0.640 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2018 | 540 | 0.630 |
Why?
| | Calcitonin | 2 | 2013 | 28 | 0.630 |
Why?
| | Tandem Mass Spectrometry | 1 | 2018 | 385 | 0.630 |
Why?
| | Adenosine Monophosphate | 1 | 2016 | 52 | 0.620 |
Why?
| | Postoperative Care | 2 | 2021 | 237 | 0.610 |
Why?
| | Protein Precursors | 2 | 2013 | 130 | 0.590 |
Why?
| | Infant, Newborn | 8 | 2019 | 5045 | 0.580 |
Why?
| | Ventricular Function, Left | 1 | 2019 | 497 | 0.570 |
Why?
| | Sepsis | 3 | 2017 | 502 | 0.560 |
Why?
| | Cardiotonic Agents | 2 | 2012 | 141 | 0.550 |
Why?
| | Swine | 3 | 2022 | 725 | 0.540 |
Why?
| | C-Reactive Protein | 2 | 2013 | 349 | 0.540 |
Why?
| | Glipizide | 1 | 2013 | 6 | 0.520 |
Why?
| | Octreotide | 1 | 2013 | 26 | 0.510 |
Why?
| | Cardiovascular Surgical Procedures | 1 | 2013 | 40 | 0.500 |
Why?
| | Sulfonylurea Compounds | 1 | 2013 | 42 | 0.500 |
Why?
| | Thoracic Surgical Procedures | 1 | 2012 | 51 | 0.470 |
Why?
| | Cardiac Output, Low | 1 | 2012 | 79 | 0.450 |
Why?
| | Treatment Outcome | 8 | 2022 | 9190 | 0.440 |
Why?
| | Purines | 2 | 2022 | 166 | 0.410 |
Why?
| | Vasodilator Agents | 1 | 2012 | 336 | 0.390 |
Why?
| | Humans | 24 | 2022 | 114578 | 0.380 |
Why?
| | Hypoglycemia | 1 | 2013 | 387 | 0.370 |
Why?
| | Postoperative Period | 2 | 2022 | 310 | 0.360 |
Why?
| | Lung | 1 | 2021 | 3558 | 0.350 |
Why?
| | Kinetics | 3 | 2018 | 1759 | 0.350 |
Why?
| | Metabolome | 2 | 2021 | 294 | 0.350 |
Why?
| | Hypoxia | 2 | 2022 | 924 | 0.280 |
Why?
| | Critical Care | 2 | 2021 | 514 | 0.280 |
Why?
| | Palliative Care | 2 | 2021 | 608 | 0.270 |
Why?
| | Male | 13 | 2020 | 60818 | 0.260 |
Why?
| | Child | 8 | 2022 | 17860 | 0.260 |
Why?
| | Female | 12 | 2020 | 63070 | 0.260 |
Why?
| | Calcitonin Gene-Related Peptide | 2 | 2013 | 35 | 0.250 |
Why?
| | Circulatory Arrest, Deep Hypothermia Induced | 1 | 2022 | 26 | 0.230 |
Why?
| | Time Factors | 3 | 2019 | 7029 | 0.220 |
Why?
| | Inflammation | 1 | 2012 | 2442 | 0.220 |
Why?
| | Analysis of Variance | 2 | 2016 | 1496 | 0.210 |
Why?
| | Matrix Metalloproteinase 7 | 1 | 2020 | 11 | 0.210 |
Why?
| | Niacinamide | 1 | 2021 | 72 | 0.210 |
Why?
| | Methionine | 1 | 2021 | 158 | 0.210 |
Why?
| | Preoperative Period | 1 | 2020 | 109 | 0.200 |
Why?
| | Predictive Value of Tests | 2 | 2018 | 1994 | 0.200 |
Why?
| | Pulmonary Veins | 1 | 2020 | 83 | 0.200 |
Why?
| | Heart Function Tests | 1 | 2019 | 76 | 0.200 |
Why?
| | Serotonin Uptake Inhibitors | 1 | 2020 | 112 | 0.190 |
Why?
| | International Classification of Diseases | 1 | 2020 | 128 | 0.190 |
Why?
| | Time | 1 | 2019 | 91 | 0.180 |
Why?
| | Chromatography, Liquid | 1 | 2020 | 340 | 0.180 |
Why?
| | Surgical Procedures, Operative | 1 | 2021 | 234 | 0.180 |
Why?
| | Risk Factors | 4 | 2021 | 9078 | 0.180 |
Why?
| | Child, Preschool | 4 | 2020 | 9651 | 0.180 |
Why?
| | Rewarming | 1 | 2018 | 18 | 0.170 |
Why?
| | Matrix Metalloproteinases | 1 | 2019 | 92 | 0.170 |
Why?
| | GPI-Linked Proteins | 1 | 2018 | 56 | 0.170 |
Why?
| | Animals | 5 | 2022 | 34690 | 0.170 |
Why?
| | Serotonin | 1 | 2020 | 380 | 0.170 |
Why?
| | Mass Spectrometry | 1 | 2020 | 697 | 0.160 |
Why?
| | Hospital Mortality | 2 | 2018 | 871 | 0.160 |
Why?
| | Respiration, Artificial | 2 | 2018 | 555 | 0.160 |
Why?
| | Cardiac Catheterization | 1 | 2020 | 547 | 0.160 |
Why?
| | Heart Ventricles | 1 | 2022 | 728 | 0.150 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2019 | 386 | 0.150 |
Why?
| | Case-Control Studies | 2 | 2020 | 3249 | 0.150 |
Why?
| | Extracellular Space | 1 | 2016 | 138 | 0.150 |
Why?
| | Solubility | 1 | 2016 | 267 | 0.150 |
Why?
| | Cohort Studies | 2 | 2017 | 5000 | 0.140 |
Why?
| | Coronary Thrombosis | 1 | 2015 | 25 | 0.140 |
Why?
| | Databases, Factual | 1 | 2020 | 1161 | 0.140 |
Why?
| | Kidney | 1 | 2022 | 1197 | 0.140 |
Why?
| | Chi-Square Distribution | 1 | 2016 | 577 | 0.140 |
Why?
| | Proteomics | 1 | 2020 | 768 | 0.140 |
Why?
| | Intensive Care Units, Pediatric | 2 | 2017 | 197 | 0.140 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2015 | 74 | 0.130 |
Why?
| | Age Factors | 2 | 2020 | 3280 | 0.130 |
Why?
| | Cattle | 1 | 2016 | 964 | 0.130 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1600 | 0.130 |
Why?
| | Quality Improvement | 1 | 2021 | 947 | 0.120 |
Why?
| | Prognosis | 2 | 2019 | 3546 | 0.120 |
Why?
| | Liver Function Tests | 1 | 2013 | 116 | 0.120 |
Why?
| | Intubation | 1 | 2012 | 7 | 0.120 |
Why?
| | Algorithms | 1 | 2020 | 1502 | 0.120 |
Why?
| | Infusions, Intravenous | 1 | 2013 | 406 | 0.120 |
Why?
| | Statistics, Nonparametric | 1 | 2013 | 456 | 0.120 |
Why?
| | Retrospective Studies | 4 | 2021 | 11642 | 0.110 |
Why?
| | Logistic Models | 2 | 2020 | 2051 | 0.110 |
Why?
| | Intubation, Intratracheal | 1 | 2012 | 188 | 0.100 |
Why?
| | Linear Models | 1 | 2013 | 885 | 0.100 |
Why?
| | ROC Curve | 1 | 2012 | 489 | 0.100 |
Why?
| | Severity of Illness Index | 1 | 2017 | 2847 | 0.090 |
Why?
| | Risk Assessment | 1 | 2018 | 3208 | 0.090 |
Why?
| | Adolescent | 4 | 2020 | 18658 | 0.090 |
Why?
| | Myocardial Infarction | 1 | 2015 | 1162 | 0.080 |
Why?
| | Citalopram | 1 | 2020 | 32 | 0.050 |
Why?
| | Electrophysiological Phenomena | 1 | 2019 | 52 | 0.050 |
Why?
| | Mechanical Phenomena | 1 | 2019 | 82 | 0.050 |
Why?
| | Adult | 1 | 2020 | 32077 | 0.040 |
Why?
| | Myocardial Contraction | 1 | 2019 | 386 | 0.040 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2019 | 186 | 0.040 |
Why?
| | Odds Ratio | 1 | 2020 | 1059 | 0.040 |
Why?
| | Intensive Care Units | 1 | 2021 | 592 | 0.040 |
Why?
| | Vasoconstrictor Agents | 1 | 2017 | 121 | 0.040 |
Why?
| | Survival Rate | 1 | 2021 | 1859 | 0.040 |
Why?
| | Subtilisins | 1 | 1994 | 12 | 0.040 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2015 | 69 | 0.030 |
Why?
| | Hemodynamics | 1 | 2019 | 1103 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2454 | 0.030 |
Why?
| | Golgi Apparatus | 1 | 1994 | 103 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1217 | 0.030 |
Why?
| | Lysosomes | 1 | 1994 | 138 | 0.030 |
Why?
| | Endosomes | 1 | 1994 | 137 | 0.030 |
Why?
| | Blood Pressure | 1 | 2019 | 1726 | 0.030 |
Why?
| | Tissue Plasminogen Activator | 1 | 2015 | 239 | 0.030 |
Why?
| | Fibrinolytic Agents | 1 | 2015 | 243 | 0.030 |
Why?
| | Membrane Glycoproteins | 1 | 1994 | 494 | 0.030 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2015 | 397 | 0.030 |
Why?
| | Hospitalization | 1 | 2020 | 1714 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2015 | 1294 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2019 | 3145 | 0.020 |
Why?
| | United States | 1 | 2021 | 12551 | 0.020 |
Why?
| | Young Adult | 1 | 2020 | 10987 | 0.020 |
Why?
| | Furin | 1 | 1994 | 9 | 0.010 |
Why?
| | Immunologic Techniques | 1 | 1994 | 43 | 0.010 |
Why?
| | Cell Compartmentation | 1 | 1994 | 57 | 0.010 |
Why?
| | Cytoplasm | 1 | 1994 | 296 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 1994 | 2157 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 1994 | 3011 | 0.010 |
Why?
| | Cell Line | 1 | 1994 | 2924 | 0.010 |
Why?
| | Rats | 1 | 1994 | 6201 | 0.000 |
Why?
|
|
Davidson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|